Eterna Therapeutics (ERNA) News Today → Biden replacement revealed? (From Paradigm Press) (Ad) Free ERNA Stock Alerts $1.74 -0.22 (-11.22%) (As of 09:30 AM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineQ4 2023 Cognition Therapeutics Inc Earnings Callfinance.yahoo.com - March 27 at 1:36 AMViking Therapeutics' experimental tablet helps reduce weight in small studymsn.com - March 26 at 7:53 AMERNA Stock Earnings: Eterna Therapeutics Reported Results for Q4 2023investorplace.com - March 15 at 10:03 AMEterna Therapeutics Stock (NASDAQ:ERNA) Dividends: History, Yield and Datesbenzinga.com - February 23 at 4:18 PMEterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directorsfinance.yahoo.com - February 20 at 1:20 PMEterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directorsglobenewswire.com - February 20 at 8:30 AMEterna Therapeutics files to sell 18.2M shares for holdersmsn.com - January 12 at 8:53 PMEterna Therapeutics Grants New President and CEO Sanjeev Luther Inducement Award Under Nasdaq Listing Rule 5635 (c)(4)finance.yahoo.com - January 3 at 9:06 PMEterna Therapeutics Appoints Sanjeev Luther as President and CEOfinance.yahoo.com - December 21 at 12:45 PMEterna Therapeutics names Sanjeev Luther as CEOmsn.com - December 20 at 7:56 PMEterna Therapeutics Names Sanjeev Luther as President and Chief Executive Officerfinance.yahoo.com - December 20 at 7:56 PMEterna Therapeutics launches convertible debt and warrant financing of up to $9.2Mmsn.com - December 15 at 2:55 PMEterna Therapeutics Announces $9.2 Million Convertible Debt and Warrant Financingfinance.yahoo.com - December 14 at 11:40 PMTreadwell Announces Strategic Pipeline Prioritization and Leadership Transitionsmarkets.businessinsider.com - December 6 at 8:35 PMmarketbeat.com - December 6 at 2:17 PMEterna Therapeutics Appoints James Bristol, Ph.D., Pharmaceutical Research and Drug Discovery Veteran, to Board of Directorsfinance.yahoo.com - November 1 at 1:58 PMCalidi Biotherapeutics Names Andrew Jackson CFOmarkets.businessinsider.com - October 30 at 10:42 AMCalidi Biotherapeutics Names Andrew Jackson Chief Financial Officermarketwatch.com - October 30 at 10:42 AMPositive Clinical Outcomes and Continued Genentech Support Bolster Buy Rating for Lineage Cell Therapeutics: An Analysis of OpRegen’s Potentialmarkets.businessinsider.com - October 5 at 8:08 AMStem Cell Therapy Contract Manufacturing market is projected to grow at a CAGR of 12.4% by 2033: Visiongainuk.finance.yahoo.com - September 13 at 9:53 AMInsider Stock Buying Reaches US$2.7m On Eterna Therapeuticsfinance.yahoo.com - September 8 at 5:41 PMEterna Therapeutics Teams with Lineage Cell on Transplant Therapiesfinance.yahoo.com - September 6 at 5:50 PMEterna Therapeutics Announces Initiation of Development Activities for Hypoimmune Pluripotent Cell Line for Neurology Indications Under Partnership With Lineage Cell Therapeuticsfinance.yahoo.com - September 6 at 8:47 AMEterna Therapeutics Appoints Biopharma Industry Veteran Dorothy Clarke to Board of Directorsfinance.yahoo.com - September 5 at 12:46 PMEterna Therapeutics Appoints Dorothy Clarke to Board of Directorsfinance.yahoo.com - September 5 at 12:46 PMEterna Therapeutics Announces Completion of $8.7 Million of Convertible Debt Financingfinance.yahoo.com - July 18 at 12:30 PMEterna Therapeutics Appoints Biotech Industry Veterans Brant Binder and Richard Wagner, Ph.D. to Board of Directorsfinance.yahoo.com - July 11 at 8:58 AMEterna Therapeutics Appoints Megan Yung as Chief Strategy Officer, General Counselfinance.yahoo.com - May 24 at 10:45 AMEterna Therapeutics and Factor Bioscience Announce New Data on Multi-Cell-Type Therapeutic Approach at American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meetingfinance.yahoo.com - May 17 at 1:11 PMEterna Therapeutics to Deliver Eight Presentations at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meetingfinance.yahoo.com - May 4 at 12:41 PMEterna Therapeutics Shares Rise 11% After Offer for Exacis Biotherapeutics Assetsmarketwatch.com - May 2 at 1:36 PMEterna Therapeutics Acquires Allogeneic Immuno-Oncology Platform from Exacis Biotherapeuticsfinance.yahoo.com - May 2 at 8:36 AMEterna Therapeutics Agrees to $10M Stock Purchase with Lincoln Park Capitalmarketwatch.com - April 11 at 12:42 PMEterna Therapeutics and Lincoln Park Capital Enter into a Common Stock Purchase Agreement for Up To $10 Millionfinance.yahoo.com - April 11 at 12:42 PMJeff Karp, Ph.D., Joins Eterna’s Scientific Advisory Boardfinance.yahoo.com - March 28 at 10:44 AMERNA Eterna Therapeutics Inc.seekingalpha.com - March 24 at 10:15 AMEterna Therapeutics Reports Financial Results for Fourth Quarter and Full Year 2022 and Recent Business Highlightsfinance.yahoo.com - March 20 at 7:54 PMInsiders might want to re-evaluate their US$2.7m stock purchase as Eterna Therapeutics Inc. (NASDAQ:ERNA) drops to US$16mfinance.yahoo.com - March 16 at 8:20 AMTreadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officerfinance.yahoo.com - February 3 at 10:56 PMEterna Therapeutics chief medical officer to resignmsn.com - January 26 at 5:40 PMEterna Therapeutics Names Matt Angel as Permanent President, CEO >ERNAmarketwatch.com - January 5 at 2:16 PMEterna appoints Matt Angel as CEO, Presidentmsn.com - January 4 at 1:58 PMEterna Therapeutics Appoints Matt Angel, Ph.D. as Chief Executive Officer and Presidentfinance.yahoo.com - January 4 at 1:58 PMIn a New Audio Interview, Toni Loudenbeck of Traders News Source Interviews Dr. Matt Angel, CEO Eterna Therapeuticsfinance.yahoo.com - December 20 at 8:49 AMWhat's Going On With Eterna Therapeutics Stock Today?msn.com - December 9 at 6:21 PMEterna Therapeutics Announces Research Collaboration to Develop Advanced Gene-Edited iPS Cell Therapiesfinance.yahoo.com - December 9 at 6:21 PMmarketbeat.com - December 7 at 9:43 AMmarketbeat.com - December 7 at 9:37 AMmarketbeat.com - October 19 at 11:12 AMmarketbeat.com - October 18 at 10:48 AM Get Eterna Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ERNA and its competitors with MarketBeat's FREE daily newsletter. Email Address At first glance, this chart looks like nonsense… (Ad)We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates” But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… ERNA Media Mentions By Week ERNA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ERNA News Sentiment▼0.000.44▲Average Medical News Sentiment ERNA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ERNA Articles This Week▼00▲ERNA Articles Average Week Get Eterna Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ERNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MIRA News ABVC News RDHL News AGE News BNTC News TNXP News MNPR News IMNN News PPBT News ELAB News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ERNA) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceFed launches fourth dollar overhaulStansberry ResearchNew Trump BombshellThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eterna Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
